Iter Investments

Fluence provides educational programs focused on psychedelic integration and psychedelic-assisted therapy, aimed at licensed professionals and advanced graduate students. The organization offers continuing education and certification courses that enhance the skills and knowledge of healthcare workers, enabling them to deliver effective and compassionate psychedelic therapy. While there are no specific prerequisites for enrollment, a foundational understanding of the mental health field is beneficial. The programs are interactive, incorporating discussions, demonstrations, self-reflection exercises, and role plays to facilitate learning. Although some classes are exclusively for licensed clinicians, many programs are accessible to a broader audience interested in the subject.

Psilera is focused on developing psychedelics-based drugs aimed at improving neurological health. The company utilizes its expertise in pharmaceutical and cannabis industries to create a robust intellectual property portfolio centered on analogues derived from psychoactive precursors. Psilera formulates and screens lead compounds against various neurological targets to assess their clinical potential, with a pipeline that addresses mood disorders, cognitive diseases, and addiction. By repurposing natural psychoactive products, Psilera seeks to advance next-generation therapies that enhance mental health outcomes, ultimately aiming to alleviate human suffering.